Skip to main content
Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Odyssey Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 Dec '25 Dec '24
Net Income
-148.65-129.32
Depreciation & Amortization
54.5165.07
Share-Based Compensation
-568.14-419.49
Other Operating Activities
662.52482.4
Operating Cash Flow
0.25-1.34
Capital Expenditures
-488.28-382.53
Change in Investments
-103.0797.55
Other Investing Activities
487.4381.76
Investing Cash Flow
-103.9496.78
Share Issuance / Repurchase
215.6526.98
Financing Cash Flow
215.6526.98
Net Cash Flow
-17.456.34
Free Cash Flow
-488.03-383.87
Free Cash Flow Margin
-16398.96%-8583.81%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).